Developer of Amniocentesis Dies

John Littlefield pioneered the use of the prenatal testing method in diagnosing genetic disorders in the womb.

Written byAggie Mika
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Photo courtesy of the Littlefield family

John Littlefield, a scientist and physician whose research helped bring about profound advancements in medical genetics, died from complications from dementia at his home on April 20. He was 91.

Among Littlefield’s most impactful contributions was the development of amniocentesis, a method used to diagnose genetic disorders in fetuses that involves sampling amniotic fluid for fetal DNA. This breakthrough allowed pregnant women to test for genetic diseases for the first time.

Throughout his prolific career, Littlefield contributed to many other notable scientific advances, including uncovering the role ribosomes play in protein synthesis and isolating human stem cells capable of assuming ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies